JPRN-UMIN000020968
Recruiting
未知
The clinical study to explore the effects of DPP-4 inhibitors on responses of lipid - The clinical study to explore the effects of DPP-4 inhibitors on responses of lipid
Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine0 sites60 target enrollmentFebruary 11, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients who are acute disease 2\.Patients who are past history of hypersensitivity to anagliptin 3\.Pregnant or woman of child\-bearing potential 4\.Patients who are stage5 of diabetic nephropathy 5\.Patients who are judged as inappropriate for inclusion by phsicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30
Active, not recruiting
Not Applicable
valuation of the effect of a new drug for diabetes on atherosclerosis in patients with primary failure metformiType 2 diabetesMedDRA version: 14.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2012-000152-34-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA64
Completed
Not Applicable
A clinical study to evaluate to the effects of D-psicose (D-allulose) on respiratory metabolism (meal tolerance test)JPRN-UMIN000034213Soiken Inc.48
Completed
Not Applicable
A clinical study to evaluate to the effects of D-psicose (D-allulose) on respiratory metabolism.Healthy volunteersJPRN-UMIN000033260Soiken Inc.48
Completed
Not Applicable
The effects of the combination therapy of DPP-4 inhibitor alogliptin and alfa-glucosidase inhibitor on markers of inflammation and oxidative stress - comparison between Acarbose and Voglibosetype 2 diabetes mellitusJPRN-UMIN000007714Department of Internal Medicine, School of Medicine, Keio University40